China says COVID19vaccine could be ready for public by November
BEIJING – A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up.
Representatives of the firms told AFP that they hope their vaccines will be approved after phase 3 trials as early as year-end. Wu Guizhen did not specify which vaccine she was referring to, but said "based on the phase 3 clinical results, the current progress is very smooth." Some of China's vaccine candidates have already been offered to essential workers under an emergency use programme.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China says COVID-19 vaccine could be ready for public by NovemberChinese manufacturers have been bullish about development, with companies even putting their vaccine candidates on display at a trade fair in Beijing.
Read more »
Public hospitals take breather as COVID-19 infections slow but ready for surgeWith experts sounding the alarm on a possible second spike in coronavirus transmissions, public hospitals are confident they’ll be better prepared.
Read more »
Will Covid-19 kill off Sandton and other swish business hubs?Remote working means a lower demand for office space — but Joburg has always embraced change
Read more »
Will Covid-19 kill off Sandton and other swish business hubs?Remote working means a lower demand for office space — but Joburg has always embraced change
Read more »
Tshwane leads the pack in Gauteng with new Covid-19 infectionsTshwane repored the highest number of new Covid-19 cases in Gauteng on Saturday.
Read more »
India considers emergency authorisation of vaccine as Covid-19 cases surge | News24India is considering granting an emergency authorisation for a Covid-19 vaccine, particularly for the elderly and people in high-risk workplaces, as the country's number of reported infections passed 4.75 million.
Read more »